On the other hand, although statistical significance was not reached, the use of GLP-1RAs showed a trend towards a reduced risk of nine respiratory diseases (pneumonia, pulmonary fibrosis, dyspnea, acute respiratory failure, pleural effusion, COPD, sleep apnea syndrome, and pulmonary embolism)
Caution should be observed in patients who have cardiac conditions that might be worsened by an increase in heart rate, such as tachyarrhythmias
Glucagon-like peptide-1 (GLP-1) physiologically induces glucose-dependent insulin secretion from -cells and GLP-1 analogues ameliorate hyperglycaemia in T2D patients 4,5,6
Throughout the clinical trials, nausea (12%-24%), diarrhoea (12%-22%), and vomiting (2%-13%) were the most commonly reported gastrointestinal events associated with tirzepatide [54,55,56], consistent with the results of this study
Phenolic compounds (Kuwanon C, T, E, U, K, Morusin, Mulberrofuran B) from Morus alba root bark were investigated for their multiple in vitro biological (antibacterial, antiviral, and antiinflammatory) effects
NYSE: LLY remain in short supply
